Grandi P - Search Results

1

Spear MA, Schuback D, Miyata K, Grandi P, Sun F, Yoo L, Nguyen A, Brandt CR, Breakefield XO. Spear MA, et al. Among authors: grandi p. J Virol Methods. 2003 Jan;107(1):71-9. doi: 10.1016/s0166-0934(02)00193-3. J Virol Methods. 2003. PMID: 12445940

2

Targeting HSV amplicon vectors.

Grandi P, Spear M, Breakefield XO, Wang S. Grandi P, et al. Methods. 2004 Jun;33(2):179-86. doi: 10.1016/j.ymeth.2003.11.007. Methods. 2004. PMID: 15121173

3

HSV-1 virions engineered for specific binding to cell surface receptors.

Grandi P, Wang S, Schuback D, Krasnykh V, Spear M, Curiel DT, Manservigi R, Breakefield XO. Grandi P, et al. Mol Ther. 2004 Mar;9(3):419-27. doi: 10.1016/j.ymthe.2003.12.010. Mol Ther. 2004. PMID: 15006609 Free article.

4

Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cells.

Grandi P, Fernandez J, Szentirmai O, Carter R, Gianni D, Sena-Esteves M, Breakefield XO. Grandi P, et al. Cancer Gene Ther. 2010 Sep;17(9):655-63. doi: 10.1038/cgt.2010.22. Epub 2010 May 28. Cancer Gene Ther. 2010. PMID: 20508670 Free PMC article.

5

Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector.

McKee TD, Grandi P, Mok W, Alexandrakis G, Insin N, Zimmer JP, Bawendi MG, Boucher Y, Breakefield XO, Jain RK. McKee TD, et al. Among authors: grandi p. Cancer Res. 2006 Mar 1;66(5):2509-13. doi: 10.1158/0008-5472.CAN-05-2242. Cancer Res. 2006. PMID: 16510565 Free article.

6

Viral vectors for therapy of neurologic diseases.

Choudhury SR, Hudry E, Maguire CA, Sena-Esteves M, Breakefield XO, Grandi P. Choudhury SR, et al. Among authors: grandi p. Neuropharmacology. 2017 Jul 1;120:63-80. doi: 10.1016/j.neuropharm.2016.02.013. Epub 2016 Feb 21. Neuropharmacology. 2017. PMID: 26905292 Free PMC article. Review.

7

Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses.

Bozac A, Berto E, Vasquez F, Grandi P, Caputo A, Manservigi R, Ensoli B, Marconi P. Bozac A, et al. Among authors: grandi p. Vaccine. 2006 Nov 30;24(49-50):7148-58. doi: 10.1016/j.vaccine.2006.06.061. Epub 2006 Jul 12. Vaccine. 2006. PMID: 16884834

8

Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection.

Hong CS, Fellows W, Niranjan A, Alber S, Watkins S, Cohen JB, Glorioso JC, Grandi P. Hong CS, et al. Among authors: grandi p. Gene Ther. 2010 Oct;17(10):1200-5. doi: 10.1038/gt.2010.66. Epub 2010 May 13. Gene Ther. 2010. PMID: 20463757 Free PMC article.

9

Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection.

Caselli E, Grandi P, Argnani R, Balboni PG, Selvatici R, Manservigi R. Caselli E, et al. Among authors: grandi p. Intervirology. 2001;44(1):1-7. doi: 10.1159/000050023. Intervirology. 2001. PMID: 11223713

10

Design and application of oncolytic HSV vectors for glioblastoma therapy.

Grandi P, Peruzzi P, Reinhart B, Cohen JB, Chiocca EA, Glorioso JC. Grandi P, et al. Expert Rev Neurother. 2009 Apr;9(4):505-17. doi: 10.1586/ern.09.9. Expert Rev Neurother. 2009. PMID: 19344302 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters